KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) FCF Margin: 2010-2024

Historic FCF Margin for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to 3.43%.

  • Emergent BioSolutions' FCF Margin fell 5281.00% to -2.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year decrease of 1482.00%. This contributed to the annual value of 3.43% for FY2024, which is 2801.00% up from last year.
  • Per Emergent BioSolutions' latest filing, its FCF Margin stood at 3.43% for FY2024, which was up 113.96% from -24.58% recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' FCF Margin registered a high of 25.04% during FY2020, and its lowest value of -24.86% during FY2022.
  • In the last 3 years, Emergent BioSolutions' FCF Margin had a median value of -24.58% in 2023 and averaged -15.34%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by 3,028bps in 2022, then skyrocketed by 2,801bps in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' FCF Margin stood at 25.04% in 2020, then slumped by 1,962bps to 5.42% in 2021, then plummeted by 3,028bps to -24.86% in 2022, then rose by 28bps to -24.58% in 2023, then surged by 2,801bps to 3.43% in 2024.